Replies to post #38596 on Nutra Pharma Corp (NPHC)

[RANGOLEGEND]

I am in total agreement with you on that. The financial and reputation toxicity of the company is definitely a substantial hurdle that must be overcome

But you have to keep in mind, the company is only $4 million in debt, we are talking about a biopharmaceutical company and that money can be made very rapidly if it’s products take off. You know this.

And only because of the opioid crisis and the desperate demand for an alternate, do I believe that this company NOW has a chance to succeed

If it was not for the opioid crisis I would not put a penny into the stock. The fundamentals are terrible. But those fundamentals can be very quickly taken care of if the product takes off.

And once the product takes off, the CEO will be forced to act like a responsible CEO and he will not be able any longer to just issue shares left and right and sell. He is most likely going to do an RS once the fundamentals are a bit better so that he can bring in main stream investors and institutions.

[ThinkingOutLoud]

flaflyersfan: You asked a legitimate question.

What do you think of the CEO's other penny stock?

The reply: Crickets

That speaks volumes!

Thinking